Bipolar disorder

Nearly 3% of population suffer from bipolar disorder. Therapies with ketamine administered intravenously may be a novelty in the treatment of BP. Studies have shown a rapid antidepressant effect of ketamine infusion lasting for at least 2 weeks in a significant proportion of patients receiving mood stabilizers, refractory to previous antidepressant use.